CytoDyn Inc. - a clinical-stage biotechnology company- is leading the way in developing innovative treatments for a range of therapeutic indications. The company's primary focus is on utilizing its groundbreaking novel humanized monoclonal antibody leronlimab to develop treatments for human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and even coronavirus disease (COVID-19). As part of its efforts, the company is conducting a Phase 1b/2 clinical trial to assess the efficacy of leronlimab in treating metastatic triple-negative breast cancer. CytoDyn Inc., which was previously known as RexRay Corporation, was established in 2002 and is headquartered in Vancouver, Washington.
CytoDyn Inc's ticker is CYDY
The company's shares trade on the OTC stock exchange
They are based in Vancouver, Washington
There are 11-50 employees working at CytoDyn Inc
It is https://www.cytodyn.com/
CytoDyn Inc is in the Healthcare sector
CytoDyn Inc is in the Biotechnology industry
The following five companies are CytoDyn Inc's industry peers: